fda warning letters compounded semaglutide november 2025 FDA's Coordinated Enforcement on GLP-1 Promotion & Compounding: Hims & Hers, Eli Lilly, and Novo Nordisk Receive on the Same Day Court ruling allows for FDA

What's the difference between retatrutide and compounded GLP-1 medications from compounding pharmacies

To finish up the side effects, the discontinuation rate excluding the weight loss stoppages appears at least a bit more reasonable as in most obesity trials the stop rate is usually 5-8% which only leaves the 12mg as an outlier still, but like I said earlier, we need side effects over time and just more data in general to see whats going on with that dose

Pharmacology mirrors the underlying GLP-1 pathway biology the same receptor target as the compounded counterpart

however, treatment directed at increasing HDL-C levels has not proven to reduce the risk of ASCVD [10, 16]